GH secretagogues (GHS) act on speci®c receptors at the pituitary and hypothalamic level and possess potent GHreleasing activity but also stimulate prolactin (PRL), ACTH and cortisol (F) secretion. However, hyperactivity of the HPA axis in obesity has been reported. The objective of this study was to clarify the endocrine activity of GHS in obesity. In nine obese patients (obese OB), 9 F, age, (34.8 AE 3.7 y, body mass index (BMI), 35.0 AE 2.2 kgam 2 ; WHR, 0.9 AE 0.02), 14 controls (normal subjects, NS), 14 F, 30.4 AE 0.9 y, 20.0 AE 0.4 kgam 2 ), we studied the ACTH, F and GH responses to hexarelin (HEX, 2.0 m mgakg), a peptidyl GHS, alone and preceded by alprazolam (ALP, 0.02 rngakg), and a benzodiazepine which has an inhibitory effect on corticotroph secretion. The HEX-induced ACTH response in OB was higher than that in n.s., but this difference did not attain statistical signi®cance. In n.s. the HEX-induced ACTH response was abolished by ALP (P`0.03) which, however, only blunted that in OB (P`0.02). The GH response to HEX in OB was lower (P`0.02) than that in n.s.. ALP blunted the GH response to HEX in n.s. (P`0.03) while it did not modify that in OB. The GABAergic activation by alprazolam abolishes the ACTH response to hexarelin in normal subjects, while it only blunts that in obese subjects. Moreover, alprazolam blunts the GH response to hexarelin in normal but not in obese subjects. Thus, obese patients show partial refractoriness to the inhibitory effect of alprazolam on both corticotroph and somatotroph function.
Introduction
Growth hormone (GH) secretagogues (GHS) are synthetic peptidyl and non-peptidyl molecules with a signi®cant and dose dependent GH-, PRL-, ACTHand cortisol (F)-releasing activity via the activation of speci®c receptors present at the pituitary and hypothalamic level. In normal adults the ACTH-and F-releasing activity of GHS is similar to corticotropin releasing hormone (CRH). Where-as the GH-releasing activity of GHS is probably mediated by pituitary and hypothalamic actions, the ACTH-releasing activity of GHS is totally mediated at the central level. 1,2 Alprazolam (ALP), a benzodiazepine which activates GABAergic receptors, possesses an inhibitory effect on corticotroph function, which is probably mediated by inhibition of CRH-secreting neurons. In fact, ALP inhibits the ACTH and cortisol responses to vasopressin, naloxone and stress, but not that to exogenous CRH. 3 To further clarify the mechanisms underlying the endocrine activities of GHS in humans, we studied the ACTH-and GH-releasing effects of hexarelin (HEX) alone and preceded by ALP in patients with visceral obesity. The results were compared with those recorded in normal subjects.
Subjects and methods
Nine obese patients (obese (OB), nine women, age, 34.8 AE 3.7 y; BMI, 35.0 AE 2.2 kgam 2 ; WHR, 0.9 AE 0.02) and 14 normal women (n.s., 30.4 AE 0.9 y, 20.0 AE 0.4 kgam 2 ) were studied. All subjects underwent testing with hexarelin (Europeptides, Argenteull, France, 2 mgakg i.v. at 0 min) alone or preceded by alprazolam (Pharmacia & Upjohn, USA, 0.02 mgakg o.s. at 7 90 min) and the ACTH and cortisol responses were evaluated every 15 min from 7 90 to 120 min. Plasma ACTH and F levels were measured in duplicate by radioimmunoassay (RIA). Serum GH levels (mgal) were measured by (IRMA). The hormonal responses are expressed as absolute values. The statistical analysis was carried out using non parametric Kruskal ± Wallis, Mann ± Whitney and Wilcoxon tests.
Results
The HEX-induced ACTH response in OB (38.5AE 8.4 pgal) was higher than that in n.s. (27.1 AE 3.2 pgal) but this difference did not attain statistical signi®cance. On the other hand the F response to HEX in OB (137.5AE 12.7 mgal) overlapped with that in n.s. (130.4AE 8.8 mgal) .
In n.s. the HEX-induced ACTH peak response was abolished by ALP (8.6 AE 2.4 P`0.03), which only blunted that in OB (12.7 AE 2.1, P`0.02). After ALP pretreatment HEX was unable to induce any increase in F levels in n.s.. In OB HEX was able to stimulate F levels even after ALP pretreatment (80.8AE 7.9 mgal, P 0.01). The GH response to HEX in OB was lower than that in n.s. (18.2AE 3.8 vs 58.1 AE 10.3 mgal, P`0.00l). ALP pretreatment blunted the GH response to HEX in n.s. (31.0 AE 7.1 mgal, P`0.03), while it did not modify that in OB (14.5 AE 5.3 mgal).
Discussion
The results of the present study show that the GABAergic activation by alprazolam abolishes the ACTH response to hexarelin in normal subjects while it only blunts that in obese subjects. Moreover, alprazolam blunts the GH response to hexarelin in normal but not in obese subjects. Hyperactivity of HPA axis in visceral obesity has been reported by some but not by others. 4 Our ®ndings, showing that the ACTH response to HEX in obese patients tends to be more marked than in normal subjects, agree with the existence of HPA hyperactivity in obesity. In physiological conditions, the ACTH-releasing activity of GHS is due to Cn.s.-mediated mechanisms. 1, 2 In fact, the ACTH and F response to GHS is abolished by pituitary stalk transection in animals, 1,2 while GHS are unable to stimulate ACTH release from rat as well as from human pituitary. 1, 2 Our ®ndings showing the inhibitory effect of alprazolam, a benzodiazepine which inhibits corticotroph function via central mechanisms, 3 on the hexarelininduced ACTH response indicate that in obese as well as in normal subjects the ACTH-releasing activity of GHS takes place via Cn.s. mediated mechanisms. 5 However, differently from in normals, in obese patients the corticotroph responsiveness to the hexarelin was not fully abolished by alprazolam. Thus, in patients with visceral obesity the stimulatory effect of GHS on HPA is partially refractory to the inhibitory effect of alprazolam-activated central mechanisms.
Interestingly, alprazolam pretreatment did not modify the low somatotroph responsiveness to hexarelin in obese patients, while it blunted that in normal young subjects. This evidence agrees with the hypothesis that obese patients are partially refractory to the neuroendocrine activities of alprazolam and suggest that GABAergic mechanisms could play a role in the neuroendocrine activities of GHS.
